12/4/2018Sartorius and Immunochina Partner to Advance Immunotherapy Development

12/3/2018AstraZeneca to Promote R&D of Seven New Drugs in China

12/3/2018CASI Pharma Announces Chinese Approval of EVOMELA

12/3/2018Helsinn and Mundipharma China Announce Approval of ALOXI IV by the NMP...

12/3/2018Is Renewed MNC Optimism in China Sustainable amid Intensified Cost Con...

12/3/2018NHC and SMIA Reach Consensus about Use of HTA for BMI Reimbursement Li...

12/3/2018Shionogi/Roche's Flu New Drug Xofluza Submits IND in China

11/30/2018Recent Official and Executive Moves

11/30/2018Financial-related Company News in Brief

11/30/2018NMPA Issues Announcement for One-time Import of Reference Drugs for Bi...

11/30/2018NMPA Signs MOU with MPP after Joining WHO’s COPP

11/30/2018Innovent and Chi-Med to Evaluate Combination of Sintilimab and Fruquin...

11/30/2018China Faces Flu Vaccines Shortage amid Rising Demand and Manufacturing...

11/30/2018MacroGenics and Zai Lab Announce License Agreement of Three I/O Drugs ...

11/30/2018Chinese Heparin Maker Yibin Lihao Bio Banned by EMA over Contamination...

11/29/2018Online Healthcare Platform Jianke.com to Form Alliance with Pfizer

11/29/2018Chi-Med Signs Agreements To Test Two New Drug Candidates

11/29/2018IQVIA: The Chinese Pharmaceutical Market to Grow at 5.5% CAGR by 2022

11/29/2018WuXi Biologics and ABL Enter Development and Clinical Manufacturing Pa...

11/29/2018Who Are the Investors Supporting He Jiankui, the Chinese Scientist beh...

11/29/2018Immunitor to Initiate Clinical Development of Oral TB Vaccine in China

11/29/2018Datwyler to Enter China to Meet Needs for Injectable Drug Components

11/29/2018TRACON Pharma and I-Mab Biopharma Announce Partnerships for Multiple I...

11/29/2018WuXi AppTec Launches $1B+ IPO in Hong Kong

11/29/2018Neuro-specialist BioHaven Sets Up Shop in China

11/28/2018China Approves Gilead’s HCV Drug HARVONI

11/28/2018Revenues Up and Profits Down for Chinese Pharma in First Ten Months of...

11/28/2018Zymeworks and BeiGene Announce License Agreement for HER2-Targeted Can...

11/27/2018WuXi Biologics Begins Construction of A Major Biologics Center in Shan...

11/27/2018WSJ: Drugmakers Gain More Access to China, But at a Price

Page:306/779 Total number of articles:23361: [First][<<] [304] [305] [306] [307] [308] [>>] [End]